HCA:NYE-HCA Holdings Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 403.28

Change

0.00 (0.00)%

Market Cap

USD 104.23B

Volume

0.82M

Analyst Target

USD 147.05
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
UHS Universal Health Services Inc

N/A

USD 16.11B
THC Tenet Healthcare Corporation

N/A

USD 16.10B
DVA DaVita HealthCare Partners Inc

N/A

USD 13.76B
EHC Encompass Health Corp

N/A

USD 9.32B
CHE Chemed Corp

N/A

USD 8.90B
CON Concentra Group Holdings Paren..

N/A

USD 2.93B
ARDT Ardent Health Partners, Inc.

N/A

USD 2.59B
NHC National HealthCare Corporatio..

N/A

USD 1.96B
AMN AMN Healthcare Services Inc

N/A

USD 1.62B
AGL agilon health Inc

N/A

USD 1.54B

ETFs Containing HCA

FHI-B:CA CI Health Care Giants Cov.. 5.36 % 0.00 %

N/A

CAD 0.05B
ZWHC:CA BMO Covered Call Health C.. 4.84 % 0.00 %

N/A

N/A
YALL God Bless America ETF 4.46 % 0.00 %

N/A

N/A
MHG:AU Magellan Global Equities 4.24 % 0.00 %

N/A

USD 0.11B
MGE:AU 4.11 % 0.00 %

N/A

N/A
BWTG 4.00 % 0.00 %

N/A

N/A
PKW Invesco BuyBack Achievers.. 3.61 % 0.62 %

N/A

USD 1.20B
XHS SPDR® S&P Health Care Se.. 2.07 % 0.35 %

N/A

USD 0.08B
XLVE:CA Mulvihill U.S. Health Car.. 1.79 % 0.00 %

N/A

N/A
NFRA:LSE Rize Global Sustainable I.. 1.77 % 0.00 %

N/A

USD 0.11B
ENG:PA BNP Paribas EASY ECPI Glo.. 1.12 % 0.00 %

N/A

USD 0.22B
XU61:F BNP Paribas Easy SICAV - .. 1.12 % 0.00 %

N/A

USD 0.24B
XU61:XETRA BNP Paribas EASY ECPI Glo.. 1.12 % 0.00 %

N/A

USD 0.27B
ENGUS:PA BNP Paribas Easy ECPI Glo.. 1.12 % 0.00 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
NASH 0.00 % 0.49 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

N/A

CAD 0.07B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 48.99% 78% C+ 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 48.99% 78% C+ 90% A-
Trailing 12 Months  
Capital Gain 63.95% 74% C 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 63.95% 74% C 89% A-
Trailing 5 Years  
Capital Gain 234.89% 94% A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 234.89% 94% A 92% A
Average Annual (5 Year Horizon)  
Capital Gain 30.46% N/A N/A 89% A-
Dividend Return 31.37% N/A N/A 88% B+
Total Return 0.92% N/A N/A 21% F
Risk Return Profile  
Volatility (Standard Deviation) 36.83% N/A N/A 26% F
Risk Adjusted Return 85.17% N/A N/A 92% A
Market Capitalization 104.23B 100% F 98% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.